Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.87K Buy
164
+15
+10% +$700 ﹤0.01% 1026
2026
Q1
$5.38K Buy
+149
New +$6.23K ﹤0.01% 1210
2025
Q2
– Sell
-11
Closed -$459 – 1311
2025
Q1
$459 Buy
11
+2
+22% +$104 ﹤0.01% 1322
2024
Q4
$528 Buy
9
+1
+13% +$59 ﹤0.01% 1217
2024
Q3
$552 Buy
+8
New +$517 ﹤0.01% 1189

Other funds holding BRKR

CVA Family Office's BRKR Position: Q2 2026 in Review

CVA Family Office increased its Bruker (BRKR) stake by 10% in Q2 2026, buying an estimated $700 and bringing the position to 164 shares worth $9.87K. The position accounts for ﹤0.01% of the portfolio, ranked #1026.

CVA Family Office first reported a position in BRKR in Q3 2024 and has held it in 5 quarters since. 417 funds tracked by Wall St. Rank hold BRKR as of Q2 2026.

  • CVA Family Office held 164 shares of Bruker worth $9.87K as of Q2 2026.
  • CVA Family Office bought 15 Bruker shares in Q2 2026, an estimated $700.
  • Bruker made up ﹤0.01% of CVA Family Office's portfolio in Q2 2026, its #1026 holding.
  • CVA Family Office first reported a position in Bruker in Q3 2024 and has held it in 5 quarters since.
  • 417 funds tracked by Wall St. Rank held Bruker as of Q2 2026.

Based on CVA Family Office's 13F filing for Q2 2026, filed 7 Aug 2026.